Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (40)COVID-19 (36)

Type

TypeGuidance (4955)Indicators (319)News (351)NICE advice (498)Quality standards (257)Research recommendations (1786)

Status

StatusAwaiting development (335)Discontinued (466)In consultation (12)In development (429)Published (2572)Topic prioritisation (385)

Last updated

Last updatedLast 3 months (205)Last 6 months (382)Last year (707)Last 3 years (1441)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (27)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (392)COVID-19 rapid guidelines (27)Diagnostics guidance (89)Health technology evaluations (64)HealthTech guidance (768)Highly specialised technologies guidance (48)Interventional procedures guidance (1005)Medical technologies guidance (149)Medicines practice guidelines (5)NICE guidelines (579)Public health guidelines (89)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2308)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)NICE reviews (2)

Showing 2416 to 2430 of 8913 results

Sort by

Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Cefepime–enmetazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia TS ID 12035
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Human immunoglobulin with recombinant human hyaluronidase for maintenance treatment of multifocal motor neuropathy in people of any age TSID 12033
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Tolebrutinib for treating primary progressive multiple sclerosis [ID6574]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
160
161
Current page 162
163
164
…
595
Page 162 of 595
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.